← Azimuth Daily
Capturing data…
Capturing data…
MON, 9 NOV · 75 ITEMS
"Semaglutide improves cardiac structure and function in heart failure with preserved ejection fraction and obesity" — Nature Medicine · Science & Medicine
This is a peer-reviewed study published in *Nature Medicine* showing that (the active ingredient in drugs like Ozempic and Wegovy) improves heart structure and function in patients with heart failure with preserved ejection fraction (HFpEF) and obesity. The paper reports that the leads to beneficial and better pumping performance in this specific patient group, beyond its known effects on weight loss and glycemic control.
The claim is highly solid as it comes directly from a primary source: a paper in *Nature Medicine* with a registered DOI. The journal is a top-tier peer-reviewed outlet, so the findings have undergone rigorous scientific review. The reporting here is essentially the paper itself, so there is no intermediary distortion.
The paper is genuinely new, published in 2026 with no indication of resurfacing older material.